Clinical Trial Update: Carbetocin at Elective Cesarean Delivery [NA]

View source ↗

Summary

Clinical trial update indicating completion of a study evaluating carbetocin for use at elective cesarean delivery to prevent postpartum hemorrhage.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postpartum Hemorrhage

Drugs mentioned

• Carbetocin (carbetocin)

Snippet

Sponsor: Samuel Lunenfeld Research Institute, Mount Sinai Hospital | Conditions: Postpartum Hemorrhage | NA | Status: COMPLETED